iatroX logo
brainstormaskiatroXquizcpdknowledge centrehow it worksaboutblog
Knowledge Centre / Giant Cell Arteritis (GCA)

Giant Cell Arteritis (GCA)

Diagnosis and management of temporal arteritis.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 30 August 2025
RheumatologyOphthalmology

Clinical Guidelines

British Society for Rheumatology guideline on management of adult giant cell arteritis
National
CKS: Diagnosis of Giant Cell Arteritis
National
CKS: Giant Cell Arteritis
National
CKS: Management of Giant Cell Arteritis
National
NICE guideline [NG180]
National

Recent iatroX Q&As

  • What are the key clinical features that suggest a diagnosis of Giant Cell Arteritis in a patient presenting with headache?Updated: 8/16/2025
  • Which laboratory tests are most useful in the initial assessment of suspected Giant Cell Arteritis?Updated: 8/16/2025
  • What is the recommended first-line treatment for a patient diagnosed with Giant Cell Arteritis?Updated: 8/16/2025
  • When should I consider referring a patient with suspected Giant Cell Arteritis to a specialist?Updated: 8/16/2025
  • How should I monitor a patient with Giant Cell Arteritis for potential complications during treatment?Updated: 8/16/2025
ask iatroX
privacy terms faq
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play